siRNA‐cell‐penetrating peptides complexes as a combinatorial therapy against chronic myeloid leukemia using BV173 cell line as model

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Controlled Release

• Publication date

  2017-01-10

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.jconrel.2016.11.027PMID 27890856
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• siRNAs encapsulated in recombinant capsid protein derived from Dengue serotype 2 virus inhibits the four serotypes of the virus and proliferation of cancer cells.

  2015cited by this paper
• CancerPPD: a database of anticancer peptides and proteins

  2014cited by this paper
• Computational methods for microRNA target prediction.

  2014cited by this paper
• Nucleic acid delivery by cell penetrating peptides derived from dengue virus capsid protein: design and mechanism of action

  2014cited by this paper
• Computational Methods for MicroRNA Target Prediction

  2014cited by this paper
• Cell-penetrating peptides: design, synthesis, and applications.

  2014cited by this paper
• Cell‐penetrating peptides: A tool for effective delivery in gene‐targeted therapies

  2014cited by this paper
• Intracellular Nucleic Acid Delivery by the Supercharged Dengue Virus Capsid Protein

  2013cited by this paper
• Bioportides: Bioactive cell‐penetrating peptides that modulate cellular dynamics

  2013cited by this paper
• The background, discovery and clinical development of BCR-ABL inhibitors.

  2013cited by this paper
• miRBase: annotating high confidence microRNAs using deep sequencing data

  2013cited by this paper
• Occurrence and current management of side effects in chronic myeloid leukemia patients treated frontline with tyrosine kinase inhibitors.

  2013influential reference
• Targeting RAS/RAF/MEK/ERK signaling in metastatic melanoma

  2013cited by this paper
• IL-7R-mediated signaling in T-cell acute lymphoblastic leukemia.

  2013cited by this paper
• From antimicrobial to anticancer peptides. A review

  2013cited by this paper
• Investigating siRNA delivery to chronic myeloid leukemia K562 cells with lipophilic polymers for therapeutic BCR-ABL down-regulation.

  2013cited by this paper
• Quantifying molecular partition of cell‐penetrating peptide–cargo supramolecular complexes into lipid membranes: optimizing peptide‐based drug delivery systems

  2013cited by this paper
• Role of ABL family kinases in cancer: from leukaemia to solid tumours

  2013cited by this paper
• Cell-penetrating peptides (CPPs) as a vector for the delivery of siRNAs into cells.

  2013cited by this paper
• Peptides as models for the structure and function of viral capsid proteins: Insights on dengue virus capsid.

  2013cited by this paper
• Natural products: a continuing source of novel drug leads.

  2013cited by this paper
• Nucleic acid delivery: the missing pieces of the puzzle?

  2012cited by this paper
• Peptides for cell-selective drug delivery.

  2012cited by this paper
• Fiji: an open-source platform for biological-image analysis

  2012cited by this paper
• Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides.

  2012cited by this paper
• Bioportide: an emergent concept of bioactive cell-penetrating peptides

  2012cited by this paper
• Cell-penetrating peptides for the delivery of nucleic acids

  2012cited by this paper
• Cell-penetrating peptides: classes, origin, and current landscape.

  2012cited by this paper
• Roles for microRNAs in conferring robustness to biological processes.

  2012cited by this paper
• CPPsite: a curated database of cell penetrating peptides

  2012cited by this paper
• Potential efficacy of cell-penetrating peptides for nucleic acid and drug delivery in cancer.

  2011cited by this paper
• Translocation of HIV TAT peptide and analogues induced by multiplexed membrane and cytoskeletal interactions

  2011cited by this paper
• Gene expression profiles in BCL11B-siRNA treated malignant T cells

  2011cited by this paper
• Weak Seed-Pairing Stability and High Target-Site Abundance Decrease the Proficiency of lsy-6 and Other miRNAs

  2011cited by this paper
• Antimicrobial peptides with cell-penetrating peptide properties and vice versa

  2011influential reference
• ABL1 fusion genes in hematological malignancies: a review

  2011cited by this paper
• Emerging links between CDK cell cycle regulators and Wnt signaling.

  2010cited by this paper
• Delivery of therapeutic shRNA and siRNA by Tat fusion peptide targeting BCR-ABL fusion gene in Chronic Myeloid Leukemia cells.

  2010cited by this paper
• Small interfering RNA against BCR-ABL transcripts sensitize mutated T315I cells to nilotinib

  2010cited by this paper
• In vivo biodistribution and efficacy of peptide mediated delivery.

  2010cited by this paper
• Production of glycoprotein-deleted rabies viruses for monosynaptic tracing and high-level gene expression in neurons

  2010cited by this paper
• Treatment options for patients with chronic myeloid leukemia who are resistant to or unable to tolerate imatinib.

  2010cited by this paper
• Escherichia coli Cell Surface Perturbation and Disruption Induced by Antimicrobial Peptides BP100 and pepR*

  2010cited by this paper
• I-TASSER: a unified platform for automated protein structure and function prediction

  2010cited by this paper
• Quantum dot conjugates for targeted silencing of bcr/abl gene by RNA interference in human myelogenous leukemia K562 cells.

  2010cited by this paper
• Mechanisms of miRNA-mediated post-transcriptional regulation in animal cells.

  2009cited by this paper
• Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics

  2009cited by this paper
• Origins and Mechanisms of miRNAs and siRNAs.

  2009cited by this paper
• Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids.

  2009cited by this paper
• Interactions between octaarginine and U-937 human macrophages: global gene expression profiling, superoxide anion content, and cytokine production.

  2009cited by this paper
• Aging of the inceptive cellular population: the relationship between stem cells and aging

  2009cited by this paper
• Translation of the Philadelphia chromosome into therapy for CML.

  2008cited by this paper
• Widespread changes in protein synthesis induced by microRNAs

  2008cited by this paper
• Chronic myeloid leukaemia.

  2007cited by this paper
• Repression of protein synthesis by miRNAs: how many mechanisms?

  2007cited by this paper
• Insights into the kinetics of siRNA-mediated gene silencing from live-cell and live-animal bioluminescent imaging

  2006cited by this paper
• Inhibition of bcr‐abl and/or c‐abl gene expression by small interfering, double‐stranded RNAs

  2004cited by this paper
• Analysis of cell cycle by flow cytometry.

  2004cited by this paper
• Chronic myeloid leukemia: current treatment options.

  2001cited by this paper
• Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease

  1999cited by this paper
• Cluster analysis and display of genome-wide expression patterns.

  1998cited by this paper
• A flow cytometric method using Hoechst 33342 and propidium iodide for simultaneous cell cycle analysis and apoptosis determination in unfixed cells.

  1994cited by this paper
• A pragmatic approach to the analysis of DNA histograms with a definable G1 peak.

  1987cited by this paper
• Advances in Drug Delivery

  1986cited by this paper
• Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67.

  1984cited by this paper
• Establishment of a Ph1-positive human cell line (BV173).

  1983cited by this paper
• I. The Background

  1974influential reference

• An overview of strategies and challenges adopted to silence BCR-ABL gene by small interfering RNA.

  2025cites this paper
• Advances in cell-penetrating peptide-based nose-to-brain drug delivery systems.

  2025cites this paper
• Unlocking Therapeutic Potential: Enhanced shRNA Delivery with Tat Peptide in the Human Respiratory Syncytial Virus Treatment

  2024cites this paper
• Functionalized extracellular nanovesicles as advanced CRISPR delivery systems.

  2024cites this paper
• Nanoplatform-Based In Vivo Gene Delivery Systems for Cancer Therapy.

  2024cites this paper
• Advancements and Future Prospects in Molecular Targeted and siRNA Therapies for Chronic Myeloid Leukemia

  2024cites this paper
• Uptake pathways of cell-penetrating peptides in the context of drug delivery, gene therapy, and vaccine development.

  2024cites this paper
• Glycopolymer-Cell-Penetrating Peptide (CPP) Conjugates for Efficient Epidermal Growth Factor Receptor (EGFR) Silencing.

  2022cites this paper
• Oleyl Conjugated Histidine-Arginine Cell-Penetrating Peptides as Promising Agents for siRNA Delivery

  2022cites this paper
• Metal Organic Frameworks: A Versatile Class of Hybrid Compounds for Luminescent Detection and Adsorptive Removal of Enviromental Hazards

  2021influential citation
• A new biology of cell penetrating peptides

  2020cites this paper
• Cell Penetrating Peptides, Novel Vectors for Gene Therapy

  2020cites this paper
• In Vitro Assays: Friends or Foes of Cell-Penetrating Peptides

  2020cites this paper
• Identification of a novel cell-penetrating peptide derived from the capsid protein of chicken anemia virus and its application in gene delivery

  2020cites this paper
• Virus-mimetic systems for cancer diagnosis and therapy.

  2020cites this paper
• Methods for CPP Functionalization

  2019cites this paper
• Transportan-derived cell-penetrating peptide delivers sirna to inhibit replication of influenza virus in vivo

  2019cites this paper
• Transportan-derived cell-penetrating peptide delivers sirna to inhibit replication of influenza virus in vivo

  2019cites this paper
• Transportan-derived cell-penetrating peptide delivers sirna to inhibit replication of influenza virus in vivo

  2019cites this paper
• Threatening cancer with nanoparticle aided combination oncotherapy

  2019cites this paper
• Combinatorial nanocarriers against drug resistance in hematological cancers: Opportunities and emerging strategies

  2019cites this paper
• Transportan-derived cell-penetrating peptide delivers siRNA to inhibit replication of influenza virus in vivo

  2019cites this paper
• Mitochondria targeting two-photon fluorescent molecules for gene transfection and biological tracking

  2019cites this paper
• Therapeutic Potential of CPPs

  2019cites this paper
• Designing improved active peptides for therapeutic approaches against infectious diseases.

  2018cites this paper
• Cellular uptake mechanism and comparative in vitro cytotoxicity studies of monomeric LMWP-siRNA conjugate

  2018cites this paper
• Nanointerventions for Gene Therapy

  2018cites this paper
• Synthetic materials at the forefront of gene delivery

  2018cites this paper
• Enhancing the Therapeutic Delivery of Oligonucleotides by Chemical Modification and Nanoparticle Encapsulation

  2017cites this paper
• High-Yield Synthesis of Monomeric LMWP(CPP)-siRNA Covalent Conjugate for Effective Cytosolic Delivery of siRNA

  2017cites this paper
• EFFECTS OF CORE AND SHELL MODIFICATION TO TETHERED NANOASSEMBLIES ON SIRNA THERAPY

  2017cites this paper
• Biomaterials for polynucleotide delivery to anchorage-independent cells.

  2017cites this paper
• Linear Peptides in Intracellular Applications.

  2017cites this paper
• RNAi prodrugs targeting Plk1 induce specific gene silencing in primary cells from pediatric T‐acute lymphoblastic leukemia patients

  2017cites this paper